202 related articles for article (PubMed ID: 7961676)
1. Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells.
Fan Z; Lu Y; Wu X; Mendelsohn J
J Biol Chem; 1994 Nov; 269(44):27595-602. PubMed ID: 7961676
[TBL] [Abstract][Full Text] [Related]
2. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor efficacy of an anti-epidermal-growth-factor-receptor monoclonal antibody and its F(ab')2 fragment against high- and low-EGFR-expressing carcinomas in nude mice.
Tosi E; Valota O; Negri DR; Adobati E; Mazzoni A; Meazza R; Ferrini S; Colnaghi MI; Canevari S
Int J Cancer; 1995 Sep; 62(5):643-50. PubMed ID: 7665239
[TBL] [Abstract][Full Text] [Related]
4. Regulation of epidermal growth factor receptor in NIH3T3/HER14 cells by antireceptor monoclonal antibodies.
Fan Z; Mendelsohn J; Masui H; Kumar R
J Biol Chem; 1993 Oct; 268(28):21073-9. PubMed ID: 8407944
[TBL] [Abstract][Full Text] [Related]
5. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
6. Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase.
Spaargaren M; Defize LH; Boonstra J; de Laat SW
J Biol Chem; 1991 Jan; 266(3):1733-9. PubMed ID: 1988447
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
[TBL] [Abstract][Full Text] [Related]
8. A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands.
Mongini PK; Blessinger CA; Chiorazzi N; Rajaram N; Rudich SM
Int Immunol; 1995 Feb; 7(2):317-30. PubMed ID: 7734425
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of epidermal growth factor receptor aggregation by an antibody directed against the epidermal growth factor receptor extracellular domain.
Carraway KL; Cerione RA
J Biol Chem; 1993 Nov; 268(32):23860-7. PubMed ID: 8226925
[TBL] [Abstract][Full Text] [Related]
10. Inability of anti-epidermal growth factor receptor monoclonal antibody to block "autocrine" growth stimulation in transforming growth factor-secreting melanoma cells.
Kudlow JE; Khosravi MJ; Kobrin MS; Mak WW
J Biol Chem; 1984 Oct; 259(19):11895-900. PubMed ID: 6090450
[TBL] [Abstract][Full Text] [Related]
11. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.
Fan Z; Lu Y; Wu X; DeBlasio A; Koff A; Mendelsohn J
J Cell Biol; 1995 Oct; 131(1):235-42. PubMed ID: 7559780
[TBL] [Abstract][Full Text] [Related]
12. Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly.
Van de Vijver MJ; Kumar R; Mendelsohn J
J Biol Chem; 1991 Apr; 266(12):7503-8. PubMed ID: 2019581
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha.
Rodeck U; Williams N; Murthy U; Herlyn M
J Cell Biochem; 1990 Oct; 44(2):69-79. PubMed ID: 2250044
[TBL] [Abstract][Full Text] [Related]
14. Receptor aggregation is necessary for activation of the soluble insulin receptor kinase.
Heffetz D; Zick Y
J Biol Chem; 1986 Jan; 261(2):889-94. PubMed ID: 3510209
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies.
Mendelsohn J
J Natl Cancer Inst Monogr; 1992; (13):125-31. PubMed ID: 1389685
[TBL] [Abstract][Full Text] [Related]
16. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.
Kawamoto T; Sato JD; Le A; Polikoff J; Sato GH; Mendelsohn J
Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1337-41. PubMed ID: 6298788
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors.
Fan Z; Shang BY; Lu Y; Chou JL; Mendelsohn J
Clin Cancer Res; 1997 Nov; 3(11):1943-8. PubMed ID: 9815583
[TBL] [Abstract][Full Text] [Related]
19. EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.
Modjtahedi H; Affleck K; Stubberfield C; Dean C
Int J Oncol; 1998 Aug; 13(2):335-42. PubMed ID: 9664130
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
